506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment
Status:
Terminated
Trial end date:
2002-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die.
PURPOSE: Phase I trial to study the effectiveness of 506U78 in treating patients who have
hematologic cancer and kidney or liver impairment.